timolol has been researched along with Conjunctival Diseases in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holló, G; Katsanos, A | 1 |
| Alkharashi, M; Ashenberg, A; Oke, I; Petersen, RA; Shah, AS | 1 |
| Batoosingh, AL; Cohen, JS; Gross, RL; Liu, CC; Safyan, E; Williams, RD | 1 |
| Delgado-Ortega, L; Díaz-Cerezo, S; Pinazo-Durán, MD; Soto-Alvarez, J; Vinuesa-Silva, I; Vinuesa-Silva, JM | 1 |
| Potop, V | 1 |
| Aptel, F; Denis, P | 1 |
| Cho, HK; Moon, JI; Park, MH | 1 |
| Bucci, MG; Centofanti, M; Manni, G; Oddone, F; Parravano, M | 1 |
| Agarwal, R; Agrawal, SS; Galpalli, ND; Gupta, SK; Saxena, R; Srivastava, S | 1 |
| Arbeille, B; Denoyer, A; Fetissof, F; Ossant, F; Patat, F; Pisella, PJ; Pourcelot, L | 1 |
| Easthope, SE; Perry, CM | 1 |
| Fiore, PM | 1 |
5 review(s) available for timolol and Conjunctival Diseases
| Article | Year |
|---|---|
Safety and tolerability of the tafluprost/timolol fixed combination for the treatment of glaucoma.
Topics: Antihypertensive Agents; Conjunctival Diseases; Drug Combinations; Glaucoma; Humans; Hyperemia; Intraocular Pressure; Medication Adherence; Prostaglandins F; Timolol | 2015 |
[Development of conjunctival hyperemia with the use of a fixed combination of latanoprost/timolol: systematic review and meta-analysis of clinical trials].
Topics: Aged; Brimonidine Tartrate; Clinical Trials as Topic; Cloprostenol; Conjunctival Diseases; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Glaucoma; Humans; Hyperemia; Latanoprost; Middle Aged; Ocular Hypertension; Odds Ratio; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Timolol; Travoprost | 2009 |
Balancing efficacy and tolerability of prostaglandin analogues and prostaglandin-timolol fixed combinations in primary open-angle glaucoma.
Topics: Adrenergic beta-Antagonists; Conjunctival Diseases; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Hyperemia; Patient Compliance; Prostaglandins F, Synthetic; Timolol | 2011 |
Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
Topics: Administration, Topical; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Conjunctival Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glaucoma, Open-Angle; Intraocular Pressure; Latanoprost; Lipids; Ocular Hypertension; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2002 |
Drug-induced ocular cicatrization.
Topics: Biopsy; Conjunctiva; Conjunctival Diseases; Echothiophate Iodide; Epinephrine; Humans; Idoxuridine; Immunosuppression Therapy; Pemphigoid, Benign Mucous Membrane; Pilocarpine; Quaternary Ammonium Compounds; Skin Diseases, Vesiculobullous; Timolol; Tretinoin | 1989 |
2 trial(s) available for timolol and Conjunctival Diseases
| Article | Year |
|---|---|
Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.
Topics: Amides; Analysis of Variance; Bimatoprost; Cloprostenol; Conjunctival Diseases; Double-Blind Method; Drug Administration Schedule; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Timolol; Treatment Outcome; Visual Acuity | 2008 |
Interleukin-1beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Conjunctival Diseases; Cross-Over Studies; Enzyme-Linked Immunosorbent Assay; Female; Glaucoma, Open-Angle; Humans; Hyperemia; Interleukin-1; Intraocular Pressure; Keratitis; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Preservatives, Pharmaceutical; Prospective Studies; Single-Blind Method; Tears; Timolol | 2005 |
5 other study(ies) available for timolol and Conjunctival Diseases
| Article | Year |
|---|---|
Treatment of Ocular Pyogenic Granuloma With Topical Timolol.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Child; Child, Preschool; Conjunctival Diseases; Female; Granuloma, Pyogenic; Humans; Male; Retrospective Studies; Timolol | 2017 |
[Effects of preservatives in anti-glaucoma agents on the ocular surface].
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Conjunctival Diseases; Corneal Diseases; Female; Glaucoma; Humans; Lacrimal Apparatus Diseases; Male; Middle Aged; Ophthalmic Solutions; Preservatives, Pharmaceutical; Quality of Life; Surveys and Questionnaires; Tears; Timolol | 2009 |
The effect of additional topical cyclosporine or vitamin A on the ocular surface during antiglaucoma medication administration.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Cloprostenol; Conjunctiva; Conjunctival Diseases; Cyclosporine; Drug Combinations; Drug Therapy, Combination; Goblet Cells; Immunosuppressive Agents; Male; Ophthalmic Solutions; Rabbits; Timolol; Travoprost; Vitamin A; Vitamins | 2012 |
Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
Topics: Adrenal Cortex Hormones; Animals; Anterior Chamber; Cholinergic Agonists; Conjunctival Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Glaucoma; Instillation, Drug; Intraocular Pressure; Latanoprost; Male; Ophthalmic Solutions; Pilocarpine; Prednisolone; Prostaglandins F, Synthetic; Rabbits; Timolol; Tonometry, Ocular; Treatment Outcome | 2007 |
Very-high-frequency ultrasound corneal imaging as a new tool for early diagnosis of ocular surface toxicity in rabbits treated with a preserved glaucoma drug.
Topics: Animals; Antihypertensive Agents; Benzalkonium Compounds; Conjunctival Diseases; Cornea; Epithelium, Corneal; Keratitis; Male; Microscopy, Electron, Scanning; Preservatives, Pharmaceutical; Prospective Studies; Rabbits; Radio Waves; Timolol; Ulcer; Ultrasonography | 2008 |